How do you approach perioperative hemostatic management for a patient with severe factor 11 deficiency <1%, without inhibitor, who has a significant postoperative bleeding history despite FFP prophylaxis who is undergoing major ENT/skull-base surgery?

This is a complex group of patients. There are systematic reviews that one could look up (Al-Housni et al., PMID 42189746). They involve various combinations of FFP transfusion, rFVIIa, and antifibrinolytics. Our practice has been to risk stratify the surgery based on the patient's personal bleeding...